机译:Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
Department of Haematology, 3RdFaculty of Medicine, Faculty Hospital Kralovske Vinohrady,Charles;
Department of Immunology and Clinical Biochemistry, 3Rd Faculty of Medicine,Charles University;
Central Laboratories of the Faculty Hospital Kralovske VinohradyDepartment of Statistics and Probability, Faculty of Informatics and Statistics,University of;
SARS-COV-2; Vaccination; Ibrutinib; Rituximab; Cellular immune response;